anmelden
SLI
2.315,50
PKT
+6,64
PKT
+0,29
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.01.15 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 12.01.15 | Givaudan Neutral | Citigroup Corp. | |
| 09.01.15 | Swiss Re neutral | Bernstein Research | |
| 09.01.15 | Roche Neutral | UBS AG | |
| 09.01.15 | Zurich Insurance Sell | Société Générale Group S.A. (SG) | |
| 09.01.15 | Givaudan buy | Deutsche Bank AG | |
| 08.01.15 | Givaudan overweight | JP Morgan Chase & Co. | |
| 08.01.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 08.01.15 | UBS Neutral | Merrill Lynch & Co., Inc. | |
| 08.01.15 | UBS Underperform | Merrill Lynch & Co., Inc. | |
| 08.01.15 | ABB (Asea Brown Boveri) Sell | Société Générale Group S.A. (SG) | |
| 08.01.15 | Givaudan Outperform | Credit Suisse Group | |
| 07.01.15 | Givaudan Neutral | BNP PARIBAS | |
| 07.01.15 | UBS overweight | Barclays Capital | |
| 06.01.15 | UBS Neutral | UBS AG | |
| 06.01.15 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.01.15 | Nestlé Equal weight | Barclays Capital | |
| 05.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 05.01.15 | Roche overweight | JP Morgan Chase & Co. | |
| 22.12.14 | Roche Outperform | BNP PARIBAS | |
| 22.12.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.12.14 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.12.14 | Holcim buy | Deutsche Bank AG | |
| 18.12.14 | Nestlé Sell | Goldman Sachs Group Inc. | |
| 16.12.14 | Zurich Insurance Hold | Deutsche Bank AG | |
| 16.12.14 | Holcim buy | UBS AG | |
| 16.12.14 | Swiss Re buy | Deutsche Bank AG | |
| 16.12.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 16.12.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 15.12.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.12.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 12.12.14 | UBS buy | Kepler Cheuvreux | |
| 12.12.14 | Novartis buy | UBS AG | |
| 11.12.14 | Roche buy | UBS AG | |
| 11.12.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.12.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.12.14 | Roche overweight | JP Morgan Chase & Co. | |
| 10.12.14 | Zurich Insurance neutral | JP Morgan Chase & Co. | |
| 10.12.14 | Holcim Neutral | Merrill Lynch & Co., Inc. | |
| 10.12.14 | Holcim Underperform | Merrill Lynch & Co., Inc. |
